journal article·2024-12-27

pH-Responsive Metal-Phenolic Network Nanoparticles for Synergistic Chemo-Photodynamic Antibacterial Therapy

Ji-Rou Wu, Yi-Ru Wang, Jia-Yue Du, Ya-Li Meng, Xu-Ying Liu, Xiao-Lei Zhang, Yan-Fei Kang

ACS Applied Nano Materials· Volume 7· Issue 24
Publisher page

Abstract

The emergence of drug-resistant bacteria and their easy recurrence have been challenging in the clinical treatment of skin abscesses. Therefore, there is an urgent need to develop treatments against bacterial infections. This study developed an antibacterial PDT/CDT dual-mode treatment platform (Ce6/TA-Fe 3+ NPs) to treat subcutaneous abscesses and promote wound healing. The Ce6/TA-Fe 3+ NPs can quickly generate 1 O 2 under illumination and ·OH through the Fenton reaction in the microenvironment, leading to the eradication of biofilms. In particular, the Ce6/TA-Fe 3+ NPs demonstrated over 90% effectiveness in fighting Staphylococcus aureus ( S. aureus ) bacteria and successfully eliminated biofilms after being exposed to a 660 nm laser for 10 min. Antibacterial mechanism research showed that the Ce6/TA-Fe 3+ NPs induced a speedy rupture of the bacterial cell membranes, membrane lipid peroxidation, protein leakage, inhibition of intracellular ATP, and DNA damage based on the synergistic effect of PDT and CDT. Meanwhile, the Ce6/TA-Fe 3+ NPs demonstrated good biosafety to normal cells and can clear the bacteria from the infected wound to promote the healing process of the infected area. The experimental results in vivo demonstrated that Ce6/TA-Fe 3+ NPs effectively treated skin abscesses. Therefore, this study suggested that the Ce6/TA-Fe 3+ NPs possessed the ability to kill bacteria, eliminate biofilms, and effectively treat subcutaneous abscesses based on the synergistic mechanism of PDT and CDT, which provided the promising strategy for the antibacterial medication and treatment of subcutaneous abscesses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Laboratory Medicine, Institute of Pathogen Biology and Immunology, Zhang Jiakou Key Laboratory of Organic Light Functional Materials, Hebei Key Laboratory of Neuropharmacology and Hebei Key Laboratory of Quality & Safety Analysis-Testing for Agro-Products and Food

Hebei North University

Funding

Hebei North University

References (33)

Show source-provided references
1. 10.1038/s41586-018-0344-310.1038/s41586-018-0344-3 ↗
2. 10.1016/j.biomaterials.2016.10.04110.1016/j.biomaterials.2016.10.041 ↗
3. 10.1126/science.aaf426810.1126/science.aaf4268 ↗
4. 10.3390/microorganisms905095410.3390/microorganisms9050954 ↗
5. 10.1039/C8NR05575K10.1039/C8NR05575K ↗
6. 10.1021/acs.biomac.7b0131610.1021/acs.biomac.7b01316 ↗
7. 10.1021/acsami.7b0256210.1021/acsami.7b02562 ↗
8. 10.1021/acsnano.8b0725110.1021/acsnano.8b07251 ↗
9. 10.1039/C6CS00271D10.1039/C6CS00271D ↗
10. 10.1016/j.compositesb.2022.10994210.1016/j.compositesb.2022.109942 ↗
11. 10.1016/j.cclet.2021.11.04010.1016/j.cclet.2021.11.040 ↗
12. 10.1002/adhm.20190154210.1002/adhm.201901542 ↗
13. 10.1021/acsnano.0c0525510.1021/acsnano.0c05255 ↗
14. 10.1039/D0MH01921F10.1039/D0MH01921F ↗
15. 10.1021/acsabm.2c0013810.1021/acsabm.2c00138 ↗
16. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
17. 10.1016/j.apcatb.2021.12031510.1016/j.apcatb.2021.120315 ↗
18. 10.1002/adfm.20210313410.1002/adfm.202103134 ↗
19. 10.1021/acsami.2c0541610.1021/acsami.2c05416 ↗
20. 10.1021/acsami.1c1968110.1021/acsami.1c19681 ↗
21. 10.3390/ma1314322410.3390/ma13143224 ↗
22. 10.1016/j.nantod.2023.10207110.1016/j.nantod.2023.102071 ↗
23. 10.1021/acsanm.3c0101210.1021/acsanm.3c01012 ↗
24. 10.1016/j.jconrel.2022.04.04710.1016/j.jconrel.2022.04.047 ↗
25. 10.1021/acsnano.0c0026910.1021/acsnano.0c00269 ↗
26. 10.2217/nnm-2016-001410.2217/nnm-2016-0014 ↗
27. 10.1016/j.biomaterials.2021.12091810.1016/j.biomaterials.2021.120918 ↗
28. 10.1021/acsami.6b1551510.1021/acsami.6b15515 ↗
29. 10.1016/j.actbio.2022.07.04710.1016/j.actbio.2022.07.047 ↗
30. 10.1016/j.jcis.2019.03.05210.1016/j.jcis.2019.03.052 ↗
31. 10.1016/j.nantod.2020.10098110.1016/j.nantod.2020.100981 ↗
32. 10.1002/smll.20210149510.1002/smll.202101495 ↗
33. 10.1038/srep4297810.1038/srep42978 ↗